RPAM
CTIC

Rhenman & Partners Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$966K Buy